 | • レポートコード：B-GIR08C1594 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ダラツムマブの世界市場について調べ、まとめました。種類別セグメントは、100mg注射、400mg注射等、用途別セグメントは、原発性骨癌、続発性骨癌等に区分しました。ダラツムマブの世界市場概観、企業動向、企業別ダラツムマブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ダラツムマブの市場概観 ・ダラツムマブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ダラツムマブの企業別販売動向、市場シェア、市場集中度、競争動向 ・ダラツムマブの世界市場規模 ・ダラツムマブの北米市場分析（アメリカ、カナダ、メキシコ等） ・ダラツムマブのアメリカ市場規模推移 ・ダラツムマブのカナダ市場規模推移 ・ダラツムマブのメキシコ市場規模推移 ・ダラツムマブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ダラツムマブのドイツ市場規模推移 ・ダラツムマブのイギリス市場規模推移 ・ダラツムマブのロシア市場規模推移 ・ダラツムマブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ダラツムマブの日本市場規模推移 ・ダラツムマブの中国市場規模推移 ・ダラツムマブの韓国市場規模推移 ・ダラツムマブのインド市場規模推移 ・ダラツムマブの東南アジア市場規模推移 ・ダラツムマブの南米市場分析（ブラジル、アルゼンチン等） ・ダラツムマブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ダラツムマブの種類別分析/販売量、売上、市場シェア（100mg注射、400mg注射） ・ダラツムマブの用途別分析/市場規模（原発性骨癌、続発性骨癌） ・ダラツムマブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ダラツムマブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Daratumumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Daratumumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Johnson＆Johnson
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
100mg Injection
400mg Injection
Market Segment by Applications, can be divided into
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Daratumumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Daratumumab, with price, sales, revenue and global market share of Daratumumab in 2017 and 2018.
Chapter 3, the Daratumumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Daratumumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Daratumumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Daratumumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Daratumumab Introduction
1.2 Market Analysis by Type
1.2.1 100mg Injection
1.2.2 400mg Injection
1.3 Market Analysis by Applications
1.3.1 Multiple Myeloma
1.3.2 Diffuse Large B Cell Lymphoma
1.3.3 Follicular Lymphoma
1.3.4 Mantle Cell Lymphoma
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson＆Johnson
2.1.1 Business Overview
2.1.2 Daratumumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson＆Johnson Daratumumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Daratumumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Daratumumab Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Daratumumab Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Daratumumab Manufacturer Market Share in 2018
3.3.2 Top 6 Daratumumab Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Daratumumab Market Analysis by Regions
4.1 Global Daratumumab Sales, Revenue and Market Share by Regions
4.1.1 Global Daratumumab Sales and Market Share by Regions (2014-2019)
4.1.2 Global Daratumumab Revenue and Market Share by Regions (2014-2019)
4.2 North America Daratumumab Sales and Growth Rate (2014-2019)
4.3 Europe Daratumumab Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Daratumumab Sales and Growth Rate (2014-2019)
4.5 South America Daratumumab Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Daratumumab Sales and Growth Rate (2014-2019)
5 North America Daratumumab by Country
5.1 North America Daratumumab Sales, Revenue and Market Share by Country
5.1.1 North America Daratumumab Sales and Market Share by Country (2014-2019)
5.1.2 North America Daratumumab Revenue and Market Share by Country (2014-2019)
5.2 United States Daratumumab Sales and Growth Rate (2014-2019)
5.3 Canada Daratumumab Sales and Growth Rate (2014-2019)
5.4 Mexico Daratumumab Sales and Growth Rate (2014-2019)
6 Europe Daratumumab by Country
6.1 Europe Daratumumab Sales, Revenue and Market Share by Country
6.1.1 Europe Daratumumab Sales and Market Share by Country (2014-2019)
6.1.2 Europe Daratumumab Revenue and Market Share by Country (2014-2019)
6.2 Germany Daratumumab Sales and Growth Rate (2014-2019)
6.3 UK Daratumumab Sales and Growth Rate (2014-2019)
6.4 France Daratumumab Sales and Growth Rate (2014-2019)
6.5 Russia Daratumumab Sales and Growth Rate (2014-2019)
6.6 Italy Daratumumab Sales and Growth Rate (2014-2019)
7 Asia-Pacific Daratumumab by Country
7.1 Asia-Pacific Daratumumab Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Daratumumab Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Daratumumab Revenue and Market Share by Country (2014-2019)
7.2 China Daratumumab Sales and Growth Rate (2014-2019)
7.3 Japan Daratumumab Sales and Growth Rate (2014-2019)
7.4 Korea Daratumumab Sales and Growth Rate (2014-2019)
7.5 India Daratumumab Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Daratumumab Sales and Growth Rate (2014-2019)
8 South America Daratumumab by Country
8.1 South America Daratumumab Sales, Revenue and Market Share by Country
8.1.1 South America Daratumumab Sales and Market Share by Country (2014-2019)
8.1.2 South America Daratumumab Revenue and Market Share by Country (2014-2019)
8.2 Brazil Daratumumab Sales and Growth Rate (2014-2019)
8.3 Argentina Daratumumab Sales and Growth Rate (2014-2019)
8.4 Colombia Daratumumab Sales and Growth Rate (2014-2019)
9 Middle East and Africa Daratumumab by Countries
9.1 Middle East and Africa Daratumumab Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Daratumumab Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Daratumumab Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Daratumumab Sales and Growth Rate (2014-2019)
9.3 Turkey Daratumumab Sales and Growth Rate (2014-2019)
9.4 Egypt Daratumumab Sales and Growth Rate (2014-2019)
9.5 Nigeria Daratumumab Sales and Growth Rate (2014-2019)
9.6 South Africa Daratumumab Sales and Growth Rate (2014-2019)
10 Global Daratumumab Market Segment by Type
10.1 Global Daratumumab Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Daratumumab Sales and Market Share by Type (2014-2019)
10.1.2 Global Daratumumab Revenue and Market Share by Type (2014-2019)
10.2 100mg Injection Sales Growth and Price
10.2.1 Global 100mg Injection Sales Growth (2014-2019)
10.2.2 Global 100mg Injection Price (2014-2019)
10.3 400mg Injection Sales Growth and Price
10.3.1 Global 400mg Injection Sales Growth (2014-2019)
10.3.2 Global 400mg Injection Price (2014-2019)
11 Global Daratumumab Market Segment by Application
11.1 Global Daratumumab Sales Market Share by Application (2014-2019)
11.2 Multiple Myeloma Sales Growth (2014-2019)
11.3 Diffuse Large B Cell Lymphoma Sales Growth (2014-2019)
11.4 Follicular Lymphoma Sales Growth (2014-2019)
11.5 Mantle Cell Lymphoma Sales Growth (2014-2019)
11.6 Other Sales Growth (2014-2019)
12 Daratumumab Market Forecast (2019-2024)
12.1 Global Daratumumab Sales, Revenue and Growth Rate (2019-2024)
12.2 Daratumumab Market Forecast by Regions (2019-2024)
12.2.1 North America Daratumumab Market Forecast (2019-2024)
12.2.2 Europe Daratumumab Market Forecast (2019-2024)
12.2.3 Asia-Pacific Daratumumab Market Forecast (2019-2024)
12.2.4 South America Daratumumab Market Forecast (2019-2024)
12.2.5 Middle East and Africa Daratumumab Market Forecast (2019-2024)
12.3 Daratumumab Market Forecast by Type (2019-2024)
12.3.1 Global Daratumumab Sales Forecast by Type (2019-2024)
12.3.2 Global Daratumumab Market Share Forecast by Type (2019-2024)
12.4 Daratumumab Market Forecast by Application (2019-2024)
12.4.1 Global Daratumumab Sales Forecast by Application (2019-2024)
12.4.2 Global Daratumumab Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Daratumumab Picture
Table Product Specifications of Daratumumab
Figure Global Sales Market Share of Daratumumab by Types in 2018
Table Daratumumab Types for Major Manufacturers
Figure 100mg Injection Picture
Figure 400mg Injection Picture
Figure Daratumumab Sales Market Share by Applications in 2018
Figure Multiple Myeloma Picture
Figure Diffuse Large B Cell Lymphoma Picture
Figure Follicular Lymphoma Picture
Figure Mantle Cell Lymphoma Picture
Figure Other Picture
Figure United States Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure France Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure UK Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure China Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure India Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Daratumumab Revenue (Value) and Growth Rate (2014-2024)
Table Johnson＆Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson＆Johnson Daratumumab Type and Applications
Table Johnson＆Johnson Daratumumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Daratumumab Sales by Manufacturer (2017-2018)
Figure Global Daratumumab Sales Market Share by Manufacturer in 2017
Figure Global Daratumumab Sales Market Share by Manufacturer in 2018
Table Global Daratumumab Revenue by Manufacturer (2017-2018)
Figure Global Daratumumab Revenue Market Share by Manufacturer in 2017
Figure Global Daratumumab Revenue Market Share by Manufacturer in 2018
Figure Top 3 Daratumumab Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Daratumumab Manufacturer (Revenue) Market Share in 2018
Figure Global Daratumumab Sales and Growth Rate (2014-2019)
Figure Global Daratumumab Revenue and Growth Rate (2014-2019)
Table Global Daratumumab Sales by Regions (2014-2019)
Table Global Daratumumab Sales Market Share by Regions (2014-2019)
Table Global Daratumumab Revenue by Regions (2014-2019)
Figure Global Daratumumab Revenue Market Share by Regions (2014-2019)
Figure Global Daratumumab Revenue Market Share by Regions in 2018
Figure North America Daratumumab Sales and Growth Rate (2014-2019)
Figure Europe Daratumumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Daratumumab Sales and Growth Rate (2014-2019)
Figure South America Daratumumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Daratumumab Sales and Growth Rate (2014-2019)
Figure North America Daratumumab Revenue and Growth Rate (2014-2019)
Table North America Daratumumab Sales by Countries (2014-2019)
Table North America Daratumumab Sales Market Share by Countries (2014-2019)
Figure North America Daratumumab Sales Market Share by Countries (2014-2019)
Figure North America Daratumumab Sales Market Share by Countries in 2018
Table North America Daratumumab Revenue by Countries (2014-2019)
Table North America Daratumumab Revenue Market Share by Countries (2014-2019)
Figure North America Daratumumab Revenue Market Share by Countries (2014-2019)
Figure North America Daratumumab Revenue Market Share by Countries in 2018
Figure United States Daratumumab Sales and Growth Rate (2014-2019)
Figure Canada Daratumumab Sales and Growth Rate (2014-2019)
Figure Mexico Daratumumab Sales and Growth Rate (2014-2019)
Figure Europe Daratumumab Revenue and Growth Rate (2014-2019)
Table Europe Daratumumab Sales by Countries (2014-2019)
Table Europe Daratumumab Sales Market Share by Countries (2014-2019)
Table Europe Daratumumab Revenue by Countries (2014-2019)
Figure Europe Daratumumab Revenue Market Share by Countries (2014-2019)
Figure Europe Daratumumab Revenue Market Share by Countries in 2018
Figure Germany Daratumumab Sales and Growth Rate (2014-2019)
Figure UK Daratumumab Sales and Growth Rate (2014-2019)
Figure France Daratumumab Sales and Growth Rate (2014-2019)
Figure Russia Daratumumab Sales and Growth Rate (2014-2019)
Figure Italy Daratumumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Daratumumab Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Daratumumab Sales by Countries (2014-2019)
Table Asia-Pacific Daratumumab Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Daratumumab Sales Market Share by Countries 2018
Table Asia-Pacific Daratumumab Revenue by Countries (2014-2019)
Figure Asia-Pacific Daratumumab Revenue Market Share by Countries 2018
Figure China Daratumumab Sales and Growth Rate (2014-2019)
Figure Japan Daratumumab Sales and Growth Rate (2014-2019)
Figure Korea Daratumumab Sales and Growth Rate (2014-2019)
Figure India Daratumumab Sales and Growth Rate (2014-2019)
Figure Southeast Asia Daratumumab Sales and Growth Rate (2014-2019)
Figure South America Daratumumab Revenue and Growth Rate (2014-2019)
Table South America Daratumumab Sales by Countries (2014-2019)
Table South America Daratumumab Sales Market Share by Countries (2014-2019)
Figure South America Daratumumab Sales Market Share by Countries in 2018
Table South America Daratumumab Revenue by Countries (2014-2019)
Table South America Daratumumab Revenue Market Share by Countries (2014-2019)
Figure South America Daratumumab Revenue Market Share by Countries in 2018
Figure Brazil Daratumumab Sales and Growth Rate (2014-2019)
Figure Argentina Daratumumab Sales and Growth Rate (2014-2019)
Figure Colombia Daratumumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Daratumumab Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Daratumumab Sales by Countries (2014-2019)
Table Middle East and Africa Daratumumab Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Daratumumab Sales Market Share by Countries in 2018
Table Middle East and Africa Daratumumab Revenue by Countries (2014-2019)
Table Middle East and Africa Daratumumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Daratumumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Daratumumab Revenue Market Share by Countries in 2018
Figure Saudi Arabia Daratumumab Sales and Growth Rate (2014-2019)
Figure UAE Daratumumab Sales and Growth Rate (2014-2019)
Figure Egypt Daratumumab Sales and Growth Rate (2014-2019)
Figure Nigeria Daratumumab Sales and Growth Rate (2014-2019)
Figure South Africa Daratumumab Sales and Growth Rate (2014-2019)
Table Global Daratumumab Sales by Type (2014-2019)
Table Global Daratumumab Sales Share by Type (2014-2019)
Table Global Daratumumab Revenue by Type (2014-2019)
Table Global Daratumumab Revenue Share by Type (2014-2019)
Figure Global 100mg Injection Sales Growth (2014-2019)
Figure Global 100mg Injection Price (2014-2019)
Figure Global 400mg Injection Sales Growth (2014-2019)
Figure Global 400mg Injection Price (2014-2019)
Table Global Daratumumab Sales by Application (2014-2019)
Table Global Daratumumab Sales Share by Application (2014-2019)
Figure Global Diffuse Large B Cell Lymphoma Sales Growth (2014-2019)
Figure Global Follicular Lymphoma Sales Growth (2014-2019)
Figure Global Mantle Cell Lymphoma Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Daratumumab Sales, Revenue and Growth Rate (2019-2024)
Table Global Daratumumab Sales Forecast by Regions (2019-2024)
Table Global Daratumumab Market Share Forecast by Regions (2019-2024)
Figure North America Sales Daratumumab Market Forecast (2019-2024)
Figure Europe Sales Daratumumab Market Forecast (2019-2024)
Figure Asia-Pacific Sales Daratumumab Market Forecast (2019-2024)
Figure South America Sales Daratumumab Market Forecast (2019-2024)
Figure Middle East and Africa Sales Daratumumab Market Forecast (2019-2024)
Table Global Daratumumab Sales Forecast by Type (2019-2024)
Table Global Daratumumab Market Share Forecast by Type (2019-2024)
Table Global Daratumumab Sales Forecast by Application (2019-2024)
Table Global Daratumumab Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
びまん性大細胞型B細胞リンパ腫薬市場：世界及び中国市場分析・予測（～2024年） Diffuse Large B Cell Lymphoma Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Diffuse Large B Cell Lymphoma Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the …- 世界の濾胞性リンパ腫市場：市場規模・現状・予測 Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…
- 濾胞性リンパ腫市場：世界及び中国市場分析・予測（～2024年） Follicular Lymphoma Therapeutic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Follicular Lymphoma Therapeutic industry with a focus on the Chinese market. The report provides key statistics on the market status of the Follic…
- 世界の悪性リンパ腫市場：市場規模・現状・予測 Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have the ability to spread, they are called malignant. The lymphatic system runs throughout our bodies and is composed of lymphoid tissue, vessels, and fluid. Lymphoid tissue contains lymph nodes, which are part…
- バーキットリンパ腫治療市場：世界及び中国市場分析・予測（～2024年） Burkitt Lymphoma Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Burkitt Lymphoma Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Burkitt Ly…